Literature DB >> 32017036

S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model.

Christian Schuster1, Arnaud Huard1, Evelyn Sirait-Fischer1, Christina Dillmann1, Bernhard Brüne1,2,3,4, Andreas Weigert1,3,4.   

Abstract

The sphingolipid sphingosine-1-phosphate (S1P) fulfills distinct functions in immune cell biology via binding to five G protein-coupled receptors. The immune cell-specific sphingosine-1-phosphate receptor 4 (S1pr4) was connected to the generation of IL-17-producing T cells through regulation of cytokine production in innate immune cells. Therefore, we explored whether S1pr4 affected imiquimod-induced murine psoriasis via regulation of IL-17 production. We did not observe altered IL-17 production, although psoriasis severity was reduced in S1pr4-deficient mice. Instead, ablation of S1pr4 attenuated the production of CCL2, IL-6, and CXCL1 and subsequently reduced the number of infiltrating monocytes and granulocytes. A connection between S1pr4, CCL2, and Mϕ infiltration was also observed in Zymosan-A induced peritonitis. Boyden chamber migration assays functionally linked reduced CCL2 production in murine skin and attenuated monocyte migration when S1pr4 was lacking. Mechanistically, S1pr4 signaling synergized with TLR signaling in resident Mϕs to produce CCL2, likely via the NF-κB pathway. We propose that S1pr4 activation enhances TLR response of resident Mϕs to increase CCL2 production, which attracts further Mϕs. Thus, S1pr4 may be a target to reduce perpetuating inflammatory responses.
© 2020 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Mϕs; S1PR4; psoriasis

Year:  2020        PMID: 32017036     DOI: 10.1002/eji.201948349

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Silence of S1PR4 Represses the Activation of Fibroblast-like Synoviocytes by Regulating IL-17/STAT3 Signaling Pathway.

Authors:  Pengyu Zhang; Qiang Zhang; Zhenxia Shao
Journal:  Inflammation       Date:  2022-09-06       Impact factor: 4.657

Review 2.  Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

3.  Investigation on the Mechanism of Qubi Formula in Treating Psoriasis Based on Network Pharmacology.

Authors:  Lin Zhou; Lingyun Zhang; Disheng Tao
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-21       Impact factor: 2.629

Review 4.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Putative Genes and Pathways Involved in the Acne Treatment of Isotretinoin via Microarray Data Analyses.

Authors:  Biao Chen; Peishan Li; Jun Li; Jinping Chen
Journal:  Biomed Res Int       Date:  2020-06-29       Impact factor: 3.411

6.  2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation.

Authors:  Shih-Yi Chuang; Chi-Yuan Chen; Shih-Chun Yang; Ahmed Alalaiwe; Chih-Hung Lin; Jia-You Fang
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 7.  Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface.

Authors:  Kana Masuda-Kuroki; Anna Di Nardo
Journal:  Biology (Basel)       Date:  2022-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.